PLx Pharma Winddown Corp. Business Combination, Consideration Transferred, Equity Interests Issued and Issuable
PLx Pharma Winddown Corp. reported Business Combination, Consideration Transferred, Equity Interests Issued and Issuable of $15.05 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-08.
Discontinued › Notes
us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable · last filed 2019-03-08
- PLx Pharma Winddown Corp. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2017-12-31 was $0.00.
- PLx Pharma Winddown Corp. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2017-09-30 was $0.00.
- PLx Pharma Winddown Corp. business combination, consideration transferred, equity interests issued and issuable for fiscal 2017 was $15.05M.
| Period end | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 3 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 6 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 9 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $0.00 derived: sum of 2 quarters · filed 2019-03-08 | $15.05M 10-K · filed 2019-03-08 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $15.05M 10-Q · filed 2018-11-09 | ||
| 2017-06-30 | $15.05M 10-Q · filed 2018-08-10 |